Skip to main content
Figure 2 | Critical Care

Figure 2

From: Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

Figure 2

Ceftazidime removal by continuous venovenous haemodiafiltration. Shown is the removal of ceftazidime (administered as a 3 g/day continuous infusion) by continuous venovenous haemodiafiltration in seven critically ill patients. Data points connected by the continuous line are the mean ultrafiltrate/dialysate concentrations (± standard deviation) of ceftazidime; those connected by the dotted line are the corresponding mean serum concentrations of ceftazidime.

Back to article page